Results of low- and high-dose-rate interstitial brachytherapy for T3 mobile tongue cancer

Radiotherapy and Oncology

Volumn 68, Issue 2, 2003, Pages 123-128

  Kakimoto, Naoya ^a   Inoue, Takehiro ^b   Inoue, Toshihiko ^b   Murakami, Shumei ^a   Furukawa, Souhei ^a   Yoshida, Ken ^b   Yoshioka, Yasuo ^b   Yamazaki, Hideya ^b   Tanaka, Eiichi ^b   Shimizutani, Kimishige ^c  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c OSAKA DENTAL UNIVERSITY   (Japan)

Author keywords

High dose rate; Interstitial radiotherapy; Low dose rate; T3 Tongue carcinoma

Indexed keywords

IRIDIUM 192; IRIDIUM;

ADULT; AGED; ARTICLE; BEAM THERAPY; BRACHYTHERAPY; CANCER CONTROL; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CONTROLLED STUDY; FEMALE; HUMAN; INTERSTITIAL RADIATION; LOW ENERGY RADIATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; TONGUE CANCER; TREATMENT OUTCOME; COMPARATIVE STUDY; LYMPH NODE METASTASIS; METASTASIS; MIDDLE AGED; MORTALITY; PATHOLOGY; RADIATION INJURY; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; TONGUE TUMOR; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; BRACHYTHERAPY; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; IRIDIUM RADIOISOTOPES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIATION INJURIES; RADIOTHERAPY DOSAGE; SURVIVAL RATE; TONGUE NEOPLASMS;

EID: 12144288295     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(03)00055-0     Document Type: Article

References (24)

1. Decroix Y., Ghossein N.A. Experience of the Curie Institute in treatment of cancer of the mobile tongue: I. Treatment policies and result. Cancer. 47:1981;496-502.
2. Fein D.A., Mendenhall W.M., Parsons J.T., et al. Carcinoma of the oral tongue: a comparison of results and complications of treatment with radiotherapy and/or surgery. Head Neck. 16:1994;358-365.
3. Fujita M., Hirokawa Y., Kashiwado K., et al. Interstitial brachytherapy for stage I and II squamous cell carcinoma of the oral tongue: factors influencing local control and soft tissue complications. Int J Radiat Oncol Biol Phys. 44:1999;767-775.
4. Fujita M., Hirokawa Y., Kashiwado K., et al. An analysis of mandibular bone complications in radiotherapy for T1 and T2 carcinoma of the oral tongue. Int J Radiat Oncol Biol Phys. 34:1996;333-339.
5. Hareyama M., Nishio M., Saito A., et al. Results of cesium needle interstitial implantation for carcinoma of the oral tongue. Int J Radiat Oncol Biol Phys. 25:1993;29-34.
6. Hicks W.L., North J.H., Loree T.R., et al. Surgery as a single modality therapy for squamous cell carcinoma of the oral tongue. Am J Otolaryngol. 19:1998;24-28.
7. Horiuchi J., Okuyama T., Shibuya H., Takeda M. Results of brachytherapy for cancer of the tongue with special emphasis on local prognosis. Int J Radiat Oncol Biol Phys. 8:1982;829-835.
8. Inoue T., Teshima T., Murayama S., et al. Phase III trial of high and low dose rate interstitial radiotherapy for early oral tongue cancer. Int J Radiat Oncol Biol Phys. 36:1996;1201-1204.
9. Inoue T., Teshima T., Yoshida K., et al. Phase III trial of high- vs. low-dose-rate interstitial radiotherapy for early oral tongue cancer. Int J Radiat Oncol Biol Phys. 51:2001;171-175.
10. Lau H.Y., Hay J.H., Flores A.D., Threlfall W.J. Seven fractions of twice daily high dose-rate brachytherapy for node-negative carcinoma of the mobile tongue results in loss of therapeutic ratio. Radiother Oncol. 39:1996;15-18.
11. Leung T.W., Wong V.Y., Wong C.M., et al. High dose rate brachytherapy for carcinoma of the oral tongue. Int J Radiat Oncol Biol Phys. 39:1997;1113-1120.
12. Mazeron J.J., Crook J.M., Benck V., et al. Iridium 192 implantation of T1 and T2 carcinomas of the mobile tongue. Int J Radiat Oncol Biol Phys. 19:1990;1369-1376.
13. Matsuura K., Hirokawa Y., Fujita M., Akagi Y., Ito K. Treatment results of stage I and II oral tongue cancer with interstitial brachytherapy: maximum tumor thickness is prognostic of nodal metastasis. Int J Radiat Oncol Biol Phys. 40:1998;535-539.
14. Parker H.M. A dosage system for interstitial radium therapy. Part II: physical aspects. Br J Radiol. 11:1938;313-339.
15. Paterson R., Parker H.M. A dosage system for interstitial radium therapy. Br J Radiol. 11:1938;252-266.
16. Pernot M., Malissard L., Aletti P., Hoffstetter S., Forcard J.J., Bey P. Iridium-192 brachytherapy in the management of 147 T2N0 oral tongue carcinomas treated with irradiation alone: comparison of two treatment techniques. Radiother Oncol. 23:1992;223-228.
17. Pernot M., Malissard L., Hoffstetter S., et al. The study of tumoral, radiobiological, and general health factors that influence results and complications in a series of 448 oral tongue carcinomas treated exclusively by irradiation. Int J Radiat Oncol Biol Phys. 29:1994;673-679.
18. Prince S., Bailey B.M. Squamous carcinoma of the tongue: review. Br J Oral Maxillofac Surg. 37:1999;164-174.
19. Sandhu A.P., Robertson A.G., Soutar D.S., et al. Interstitial iridium-192 implantation for recurrent and/or locally advanced head and neck cancer. Clin Oncol. 11:1999;371-378.
20. Shibuya H., Hoshina M., Takeda M., Matsumoto S., Suzuki S., Okada N. Brachytherapy for stage I and II oral tongue cancer: an analysis of past cases focusing on control and complications. Int J Radiat Oncol Biol Phys. 26:1993;51-58.
21. Teshima T., Inoue T., Ikeda H., Murayama S., Furukawa S., Shimizutani K. Phase I/II study of high-dose rate interstitial radiotherapy for head and neck cancer. Strahlenther Onkol. 168:1992;617-621.
22. Yamazaki H., Inoue T., Yoshida K., et al. Influence of age on the results of brachytherapy for early tongue cancer. Int J Radiat Oncol Biol Phys. 49:2001;931-936.
23. Yamazaki H., Inoue T., Teshima T., et al. Tongue cancer treated with brachytherapy: is thickness of tongue cancer a prognostic factor for regional control? Anticancer-Res. 18:1998;1261-1266.
24. Yoshida K., Koizumi M., Inoue T., et al. Radiotherapy of early tongue cancer in patients less than 40 years old. Int J Radiat Oncol Biol Phys. 45:1999;367-371.